OR3D1P

Across TCGA pan-cancer cohorts, OR3D1P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of OR3D1P’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where OR3D1P RNA is repressed in tumor relative to normal tissue. In most cancer types OR3D1P is over-expressed in tumor, although a few such as COAD and KIRC show the opposite, repressed pattern.

COAD, KIRC, and PRAD are the cancer types where OR3D1P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in OR3D1P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	−0.039	.001	8	view →
KIRC	Male	II,III,IV	−0.014	.025	3	view →
PRAD	All	All	+0.122	.039	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

OR3D1P–COAD

Open the COAD breakdown →